K410-0712 Screening compound: (Z)-3-(1,3-benzodioxol-5-yl)-N~1~-[2-(4-methoxyphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-2-propenamide

K410-0712 Screening compound: (Z)-3-(1,3-benzodioxol-5-yl)-N~1~-[2-(4-methoxyphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-2-propenamide
K410-0712 Screening compound: (Z)-3-(1,3-benzodioxol-5-yl)-N~1~-[2-(4-methoxyphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-2-propenamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K410-0712
(Z)-3-(1,3-benzodioxol-5-yl)-N~1~-[2-(4-methoxyphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-2-propenamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K410-0712

Molecular Formula

C22H19N3O6S (C22 H19 N3 O6 S)

Compound Name

(Z)-3-(1,3-benzodioxol-5-yl)-N~1~-[2-(4-methoxyphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-2-propenamide

IUPAC name

(2Z)-3-(2H-13-benzodioxol-5-yl)-N-[2-(4-methoxyphenyl)-55-dioxo-2H4H6H-5lambda6-thieno[34-c]pyrazol-3-yl]prop-2-enamide

SMILES

COc(cc1)ccc1-n1nc(CS(C2)(=O)=O)c2c1NC(/C=C\c(cc1)cc2c1OCO2)=O

InChI

InChI=1S/C22H19N3O6S/c1-29-16-6-4-15(5-7-16)25-22(17-11-32(27,28)12-18(17)24-25)23-21(26)9-3-14-2-8-19-20(10-14)31-13-30-19/h2-10H,11-13H2,1H3,(H,23,26)

InChI Key

AQDMKOVXNCNLQI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04452492

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.48

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.813

Distribution Coefficient, logD

2.813

Water Solubility, LogSw

-3.61

Polar Surface Area

91.147

Acid Dissociation Constant (pKa)

11.07

Base Dissociation Constant (pKb)

-2.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

K410-0712 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with K410-0712 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K410-0712?
Check Price and Availability of K410-0712, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K410-0712 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K410-0712
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K410-0712
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K410-0712 available by request